TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07049328: HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Sponsor: HCW Biologics · Phase: PHASE1 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 30 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$385,968

Rescue Site Savings

+$263,160

Unlock Full NCT07049328 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07049328 Rescue Dossier →